Predictive model of venous thromboembolism in endometrial cancer

Gynecologic Oncology

Volumn 128, Issue 3, 2013, Pages 544-551

  Matsuo, Koji ^a   Yessaian, Annie A ^a   Lin, Yvonne G ^a,b   Pham, Huyen Q ^a   Muderspach, Laila I ^a   Liebman, Howard A ^a   Morrow, C Paul ^a   Roman, Lynda D ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Deep vein thrombosis; Endometrial cancer; Prediction; Pulmonary embolism; Risk factor; Venous thromboembolism

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HISPANIC; HUMAN; HYPOALBUMINEMIA; HYSTERECTOMY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RISK FACTOR; THROMBOCYTOSIS; VENOUS THROMBOEMBOLISM;

DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; VENOUS THROMBOEMBOLISM;

EID: 84873722449     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.12.014     Document Type: Article

References (31)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics CA Cancer J Clin 62 2012 10 29
2. M.B. Donati, and R. Lorenzet Thrombosis and cancer: 40 years of research Thromb Res 129 2012 348 352
3. A.A. Khorana Cancer and coagulation Am J Hematol 87 Suppl. 1 2012 S82 S87
4. M.A. Morgan, T.D. Iyengar, B.E. Napiorkowski, S.C. Rubin, and J.J. Mikuta The clinical course of deep vein thrombosis in patients with gynecologic cancer Gynecol Oncol 84 2002 67 71
5. X. Wang, S. Fu, R.S. Freedman, and J.J. Kavanagh Venous thromboembolism syndrome in gynecological cancer Int J Gynecol Cancer 16 Suppl. 1 2006 458 471
6. A.O. Rodriguez, A.M. Gonik, H. Zhou, G.S. Leiserowitz, and R.H. White Venous thromboembolism in uterine cancer Int J Gynecol Cancer 21 2011 870 876
7. K. Matsuo, C.M. Carter, C.P. Prather, E.H. Ahn, M.L. Eno, and D.D. Im Risk of distant metastasis after permanent inferior vena cava filter placement in ovarian cancer Am J Clin Oncol May 24 2012 [Epub ahead of print]
8. M. Monreal, J. Fernandez-Llamazares, J. Perandreu, A. Urrutia, J.C. Sahuquillo, and E. Contel Occult cancer in patients with venous thromboembolism: which patients, which cancers Thromb Haemost 78 1997 1316 1318
9. T. Satoh, K. Matsumoto, K. Uno, M. Sakurai, S. Okada, and M. Onuki Silent venous thromboembolism before treatment in endometrial cancer and the risk factors Br J Cancer 99 2008 1034 1039
10. F. Gucer, F. Moser, K. Tamussino, O. Reich, J. Haas, and G. Arikan Thrombocytosis as a prognostic factor in endometrial carcinoma Gynecol Oncol 70 1998 210 214
11. D.L. Lerner, C.S. Walsh, I. Cass, B.Y. Karlan, and A.J. Li The prognostic significance of thrombocytosis in uterine papillary serous carcinomas Gynecol Oncol 104 2007 91 94
12. R.L. Stone, A.M. Nick, I.A. McNeish, F. Balkwill, H.D. Han, and J. Bottsford-Miller Paraneoplastic thrombocytosis in ovarian cancer N Engl J Med 366 2012 610 618
13. K.N. Moore, and A.N. Fader Uterine papillary serous carcinoma Clin Obstet Gynecol 54 2011 278 291
14. M.S. Anglesio, J. George, H. Kulbe, M. Friedlander, D. Rischin, and C. Lemech IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer Clin Cancer Res 17 2011 2538 2548
15. J.L. Kashuk, E.E. Moore, J.L. Johnson, W.L. Biffl, C.C. Burlew, and C. Barnett Progressive postinjury thrombocytosis is associated with thromboembolic complications Surgery 148 2010 667 674 [discussion 74-5]
16. G. Lippi, M. Franchini, and E.J. Favaloro Thrombotic complications of erythropoiesis-stimulating agents Semin Thromb Hemost 36 2010 537 549
17. M. Trikha, and M.T. Nakada Platelets and cancer: implications for antiangiogenic therapy Semin Thromb Hemost 28 2002 39 44
18. M.M. Beckers, H.J. Ruven, F.J. Haas, P.A. Doevendans, H. ten Cate, and M.H. Prins Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism Eur J Intern Med 21 2010 289 292
19. M.F. Matos, D.M. Lourenço, C.M. Orikaza, J.A. Bajerl, M.A. Noguti, and V.M. Morelli The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6 -174GC, IL-8 -251AT and MCP-1 -2518AG in the risk of venous thromboembolism: a case-control study Thromb Res 128 2011 216 220
20. M.K. Jezovnik, and P. Poredos Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction Int Angiol 29 2010 226 231
21. P. Poredos, and M.K. Jezovnik The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis Int Angiol 26 2007 306 311
22. B.B. Aggarwal, and P. Gehlot Inflammation and cancer: how friendly is the relationship for cancer patients? Curr Opin Pharmacol 9 2009 351 369
23. E.A. Akl, S. Gunukula, M. Barba, V.E. Yosuico, F.F. van Doormaal, and S. Kuipers Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Cochrane Database Syst Rev 2011 CD006652
24. N.M. Kuderer, T.L. Ortel, and C.W. Francis Impact of venous thromboembolism and anticoagulation on cancer and cancer survival J Clin Oncol 27 2009 4902 4911
25. G.H. Lyman, A.A. Khorana, A. Falanga, D. Clarke-Pearson, C. Flowers, and M. Jahanzeb American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer J Clin Oncol 25 2007 5490 5505
26. A.M. Pishko, K.J. Smith, and M.V. Ragni Anticoagulation in ambulatory cancer patients with no indication for prophylactic or therapeutic anticoagulation. A cost-effectiveness analysis from a U.S. perspective Thromb Haemost 108 2012
27. A.L. Rodriguez, B.M. Wojcik, S.K. Wrobleski, D.D. Myers Jr., T.W. Wakefield, and J.A. Diaz Statins, inflammation and deep vein thrombosis: a systematic review J Thromb Thrombolysis 33 2012 371 382
28. S.F. Nielsen, B.G. Nordestgaard, and S.E. Bojesen Statin use and reduced cancer-related mortality N Engl J Med 367 2012 1792 1802
29. A.A. Khorana, N.M. Kuderer, E. Culakova, G.H. Lyman, and C.W. Francis Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 2008 4902 4907
30. C. Ay, D. Dunkler, C. Marosi, A.L. Chiriac, R. Vormittag, and R. Simanek Prediction of venous thromboembolism in cancer patients Blood 116 2010 5377 5382
31. N.A. Zakai, and L.A. McClure Racial differences in venous thromboembolism J Thromb Haemost 9 2011 1877 1882